Belvedere Trading Reduces $22K in Aurora Cannabis Inc. ($ACB)
Key Points
- Belvedere Trading changed its Aurora Cannabis Inc. ($ACB) stake by 100.0% last quarter, cutting to 0 shares.
- Wall Street's consensus rating on $ACB is Buy and an average price target of $6.24.
- $ACB last traded around $3.12.
Belvedere Trading reduced its position in Aurora Cannabis Inc. ($ACB), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 0 shares of Aurora Cannabis Inc. after selling 6,962 shares during the quarter.
Aurora Cannabis Inc. ($ACB) Stock
Aurora Cannabis Inc. Earnings
Analysts Set New Price Targets
About Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.